Generate a tailored SOP for Dr. Crystal Mackall. Improve your application with a focused, well-structured draft.
Crystal L. Mackall, M.D., is the Ernest Amelia Gallo Family Professor in the Department of Pediatrics at Stanford University. She is the Founding Director of the Stanford Center for Cancer Cell Therapy and the Co-Leader of the Stanford Cancer Immunotherapy Program. Her career spans decades of internationally recognized translational research focused on immune-oncology, advancing the understanding of fundamental immunology and its translation into treatments for human diseases, particularly in pediatric cancers. Dr. Mackall has led numerous first-in-human clinical trials, including innovative therapies using genetically engineered T cells. Her pioneering work established the essential role of IL-7 in T cell homeostasis and has led to significant advancements in CAR T cell therapies. Additionally, she is an active member of several prestigious organizations and has received multiple awards for her contributions to oncology research.
Stanford University • Stanford, California
Leading a research group focused on cancer immunotherapy and T cell regeneration.
Patent pending on CAR technology for targeting CD22.
Patent pending for chimeric antigen receptors.
Patent pending on CAR targeting CD276.
The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.